|
C1ORF52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.842900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.967600E-04 |
| Normal-vs-Stage2 |
1.195220E-01 |
| Normal-vs-Stage3 |
1.160130E-02 |
| Normal-vs-Stage4 |
8.670600E-01 |
| Stage1-vs-Stage2 |
3.069400E-01 |
| Stage1-vs-Stage3 |
7.835200E-01 |
| Stage1-vs-Stage4 |
5.235900E-02 |
| Stage2-vs-Stage3 |
4.976400E-01 |
| Stage2-vs-Stage4 |
3.297800E-01 |
| Stage3-vs-Stage4 |
9.888300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.761500E-03 |
| Normal-vs-AfricanAmerican |
1.662440E-02 |
| Normal-vs-Asian |
2.270000E-01 |
| Caucasian-vs-AfricanAmerican |
7.980200E-01 |
| Caucasian-vs-Asian |
8.632000E-01 |
| AfricanAmerican-vs-Asian |
9.334000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.044340E-03 |
| Normal-vs-Female |
1.694000E-01 |
| Male-vs-Female |
6.966500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.942700E-03 |
| Normal-vs-Extreme_Weight |
4.577800E-03 |
| Normal-vs-Obese |
2.582300E-02 |
| Normal-vs-Extreme_Obese |
3.975600E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.879400E-01 |
| Normal_Weight-vs-Obese |
5.120800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.787800E-01 |
| Extreme_Weight-vs-Obese |
4.601400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.712600E-01 |
| Obese-vs-Extreme_Obese |
5.829800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.317600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.064300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.439100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.182810E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.092300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.180900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.624770E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.715900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.277600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.397200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.881700E-03 |
| Normal-VS-Type2 PRCC |
3.10459999997015E-06 |
| Normal-VS-KIRP CIMP |
2.146600E-01 |
| Normal-VS-Unclassified PRCC |
1.436170E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.503500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.883670E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.821000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.46689999999772E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.503400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.307900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17969999999346E-05 |
| Normal-vs-N1 |
2.936400E-01 |
| Normal-vs-N2 |
5.425800E-01 |
| N0-vs-N1 |
2.238400E-02 |
| N0-vs-N2 |
5.113400E-01 |
| N1-vs-N2 |
9.398000E-01 |
|
|
